<?xml version="1.0" encoding="UTF-8"?>
<p>VGCV was administered through oral gavage (p.o.), starting 12 h prior to (prophylactic studies) or 1 day after (therapeutic study) Ad6 injection at the dose of 200 mg/kg, and then continued twice daily (b.i.d.) using the same dose. Control animals were gavaged with equal volume of water. CDV was injected i.p. at an initial dose of 37 mg/kg, and then continued three times weekly at the dose of 20 mg/kg. Control animals were injected with PBS.</p>
